Sobi publishes report for the second quarter 2020
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces its results for the second quarter 2020. Total revenue for the second quarter 2020 was SEK 3,070 M and EBITA was SEK 1,018 M. April—June · Total revenue of SEK 3,070 M (3,163), down 3 per cent (-4 per cent at constant exchange rates (CER)) · Adjusted EBITA[1,2] was SEK 1,018 M (1,193), with an EBITA margin[1] of 33 per cent (33) · Earnings per share (EPS) of SEK 0.96 (1.70) and adjusted EPS[1,2,3] of 0.96 SEK (2.12) · Net debt[1] of SEK 11,802 M at 30 June 2020 (15,404 at 31 Dec 2019) ·